GlycoNAVI: CheGly (Chemical Glycosylation)
ACT

Tetrocarcin A

ID Compound Name Target Name Species Assay Method Activity Value Conditions DOI
act2579Tetrocarcin AStaphylococcus aureus ATCC6538PMIC (µg/ml)2010.7164/antibiotics.33.940
act2582Tetrocarcin ABacillus subtilis No. 10707MIC (µg/ml)0.110.7164/antibiotics.33.940
act2585Tetrocarcin AKlebsiella pnerunoniae ATCC10031MIC (µg/ml)>10010.7164/antibiotics.33.940
act2588Tetrocarcin AEscherlchia coli ATCC26MIC (µg/ml)>10010.7164/antibiotics.33.940
act2591Tetrocarcin AShigella sonnei ATCC9290MIC (µg/ml)>10010.7164/antibiotics.33.940
act2594Tetrocarcin ASarcoma 180Dose (mg/kg)\nT/C25 0.7810.7164/antibiotics.33.940
act2595Tetrocarcin ASarcoma 180Dose (mg/kg)\nT/C50 0.5210.7164/antibiotics.33.940
act2596Tetrocarcin ASarcoma 180Dose (mg/kg)\nT/C75 0.4210.7164/antibiotics.33.940
act2597Tetrocarcin AP388Dose (mg/kg)\nT/C25 1.2010.7164/antibiotics.33.940
act2598Tetrocarcin AP388Dose (mg/kg)\nT/C50 1.4010.7164/antibiotics.33.940
act2599Tetrocarcin AP388Dose (mg/kg)\nT/C75 1.5010.7164/antibiotics.33.940
act2606Tetrocarcin Asarcoma 180 (s.c.-i.p.).Dose (mg/kg)\nTumor volume (mm^3)\nT/C25 1096 0.7810.7164/antibiotics.33.940
act2607Tetrocarcin Asarcoma 180 (s.c.-i.p.).Dose (mg/kg)\nTumor volume (mm^3)\nT/C50 730 0.5210.7164/antibiotics.33.940
act2608Tetrocarcin Asarcoma 180 (s.c.-i.p.).Dose (mg/kg)\nTumor volume (mm^3)\nT/C75 590 0.4210.7164/antibiotics.33.940
act2609Tetrocarcin Asarcoma 180 (s.c.-i.p.).Dose (mg/kg)\nTumor volume (mm^3)\nT/C2.5 × 6 (days 1~6) 1082 0.7710.7164/antibiotics.33.940
act2610Tetrocarcin Asarcoma 180 (s.c.-i.p.).Dose (mg/kg)\nTumor volume (mm^3)\nT/C5.0 × 6 (days 1~6) 688 0.4910.7164/antibiotics.33.940
act2611Tetrocarcin Asarcoma 180 (s.c.-i.p.).Dose (mg/kg)\nTumor volume (mm^3)\nT/C10 × 6 (days 1~6) 183 0.1310.7164/antibiotics.33.940
act2617Tetrocarcin ASarcoma 180 site: scTumorNumber of animals\nT/C%\nOptimal dose (mg/kg/day)6 82 40Route: iv Schedule: day 110.7164/antibiotics.33.940
act2618Tetrocarcin ASarcoma 180 site: scTumorNumber of animals\nT/C%\nOptimal dose (mg/kg/day)6 49 40Route: iv Schedule: day 1~510.7164/antibiotics.33.940
act2619Tetrocarcin AEhrlich carcinoma site: scTumorNumber of animals\nT/C%\nOptimal dose (mg/kg/day)5 47 25Route: ip Schedule: day 110.7164/antibiotics.33.940
act2620Tetrocarcin ALewis lung carcinoma site: scTumorNumber of animals\nT/C%\nOptimal dose (mg/kg/day)5 42 40Route: iv Schedule: day 110.7164/antibiotics.33.940
act2621Tetrocarcin ALewis lung carcinoma site: scTumorNumber of animals\nT/C%\nOptimal dose (mg/kg/day)5 33 10Route: iv Schedule: day 1~510.7164/antibiotics.33.940
act2622Tetrocarcin AEhrlich carcinoma site: ipTumorNumber of animals\nT/C%\nOptimal dose (mg/kg/day)5 125 50Route: ip Schedule: day 110.7164/antibiotics.33.940
act2623Tetrocarcin AEhrlich carcinoma site: ipTumorNumber of animals\nT/C%\nOptimal dose (mg/kg/day)5 185 5Route: ip Schedule: day 1~710.7164/antibiotics.33.940
act2624Tetrocarcin AB16 melanoma site: ipTumorNumber of animals\nT/C%\nOptimal dose (mg/kg/day)5 130 40Route: ip Schedule: day 110.7164/antibiotics.33.940
act2625Tetrocarcin AB16 melanoma site: ipTumorNumber of animals\nT/C%\nOptimal dose (mg/kg/day)5 179 15Route: ip Schedule: day 1,3,5,710.7164/antibiotics.33.940
act2626Tetrocarcin AMH134 hepatoma site: ipTumorNumber of animals\nT/C%\n(50 days survivors)\nOptimal dose (mg/kg/day)5 156 (2/5) 20Route: ip Schedule: day 110.7164/antibiotics.33.940
act2627Tetrocarcin AMH134 hepatoma site: ipTumorNumber of animals\nT/C%\nOptimal dose (mg/kg/day)5 172 2.5Route: ip Schedule: day 1~410.7164/antibiotics.33.940
act2628Tetrocarcin AP388 leukemia site: ivTumorNumber of animals\nT/C%\nOptimal dose (mg/kg/day)5 130 40Route: iv Schedule: day 110.7164/antibiotics.33.940
act2629Tetrocarcin AP388 leukemia site: ivTumorNumber of animals\nT/C%\nOptimal dose (mg/kg/day)5 157 10Route: iv Schedule: day 1~510.7164/antibiotics.33.940
act2648Tetrocarcin ASerratia marcescens ATCC 4003BacteriaMIC (µg/ml)10010.7164/antibiotics.33.940
act2649Tetrocarcin AB.subtilisBacteriaMIC (µg/ml)\nNumber of deoxysugars0.05 410.7164/antibiotics.33.940
act2655Tetrocarcin AStaphylococcus aureus 209P JC-1MIC (µg/ml)50.010.7164/antibiotics.53.227
act2656Tetrocarcin ABacillus subtilis ATCC6633MIC (µg/ml)0.1010.7164/antibiotics.53.227
act2657Tetrocarcin AMicrococcus luteus ATCC9341MIC (µg/ml)1.610.7164/antibiotics.53.227
act2658Tetrocarcin AEscherichia coli NIHJ JC-2MIC (µg/ml)>10010.7164/antibiotics.53.227
act2659Tetrocarcin APseudomonasaeruginosa A3MIC (µg/ml)>10010.7164/antibiotics.53.227
act2660Tetrocarcin ASaccharomyces cerevisiae S-100MIC (µg/ml)10010.7164/antibiotics.53.227
act2661Tetrocarcin ACandida albicaiis A9540MIC (µg/ml)>10010.7164/antibiotics.53.227
act2662Tetrocarcin AU937MIC (µg/ml)0.610.7164/antibiotics.53.227